Clinical Trial

Risk of Hysterectomy at Time of Myomectomy

Completed
View on ClinicalTrials.gov →
Summary
Uterine fibroids are the commonest tumor affecting the female reproductive tract and many instances they are asymptomatic but in some women there does appear to be an association with heavy menstrual blood loss and possibly subfertility. Classically, treatment has been surgical with hysterectomy the most common approach for women who have completed their fertility and myomectomy for those who wish to conceive. The surgery can be carried out laparoscopically, vaginally and abdominally. The aim of this study is to evaluate the risk of hysterectomy at the time of myomectomy, and the associated 30-day postoperative morbidity.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-17.
Trial Details
NCT Number NCT07365969
Lead Sponsor Ain Shams University
Conditions Myomectomy, Fibroid Uterus, Hysterectomy
Enrollment 293 participants
Start Date 2024-12-15
Primary Completion 2025-10-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-30